Efeito da angiotensina (1-7) na maturação e embriões in Vitro de oócitos bovinos

Abstract

In vitro production (IVP) is included in the third generation of assisted reproduction technologies and consists of the interaction between sperm and oocyte outside the female reproductive tract, with the formation of a new individual. However, several intraovarian factors that regulate the stages of development, follicular maturation and ovulation are still unknown and may be responsible for some failures of such biotechniques. Renin-Angiotensin System peptides, such as angiotensin (1-7), which have had their presence, production and some effects described in the ovaries) but still have poorly understood functions. New perspectives on the factors that influence the quality of the embryos produced and the mechanisms involved in the maturation from the addition of different angiotensin (1-7) concentrations in the bovine IVP. Ovarian follicles were aspirated and the COCs were distributed among four treatments: Control (C), 10-1 (T1), 10-3 (T2), 10-5 μM (T3) angiotensin (1-7) in the maturation medium. in vitro to verify the stages of meiosis and embryonic development. The addition of angiotensin peptide (1-7) in the in vitro maturation medium did not provide higher metaphase II rates than the Control group. In embryonic development, angiotensin (1-7) did not improve cleavage or the amount of total embryos, the 10-1μM group provided superior amount of initial blastocysts. However, further analysis is needed to elucidate the actions performed by angiotensin (1-7) in the in vitro production of bovine embryos